QuarterHawkSign in

Tilray Brands, Inc. (TLRY)

Healthcare

No action
Fundamental
3
Sentiment
3
Technical
3

Do Nothing: TLRY's short-term rebound is improving, but price is still below the SMA50 with MACD at -0.07 below zero, so any limit pullback is countertrend, while a breakout above 4.95 only offers 0.58 R/R with the required 4.09 structure stop.

Analysis as of 2026-08-05· about 2 trading days ago

Company overview

Tilray Brands, Inc. is a global consumer packaged goods company focused on cannabis cultivation, processing, marketing, and sales. It operates across Canada, the U.S., Europe, Australia, New Zealand, and Latin America, with divisions in Cannabis, Distribution, Beverage Alcohol, and Wellness. The company offers medical and adult-use cannabis products, pharmaceutical goods, alcoholic beverages, and wellness items under brands like Tilray and Aphria.

Fundamental

fair
Fundamental3
Mixed fundamentals

Revenue growth and positive adjusted EBITDA are offset by ongoing GAAP losses and negative cash flow.

Mixed fundamentals: FY2026 revenue rose ~11% to ~$915M and adjusted EBITDA was ~$61M, but GAAP net loss was ~$105M and operating cash flow remained negative; liquidity appears adequate with ~$226M cash vs ~$199M debt.

Sentiment

fair
Sentiment3
Forming / mixed

Retail chatter is active, but media coverage is neutral and lacks a clear catalyst.

TLRY’s near-term narrative is anchored by FY2026 results highlighting record revenue/adjusted EBITDA (announced 2026-07-28) and the ZONNA THC pouch launch (announced 2026-07-23), but third-party media tone over the last ~14d is only net-neutral and the 30–90d baseline is too sparse for a reliable sentiment delta. No regulator-confirmed investigations surfaced (legal search partially limited by CAPTCHA), leaving a mixed post-earnings setup rather than a clean catalyst-driven run.

Technical

fair
Technical3
Countertrend bounce

Short-term momentum has improved, but the stock remains below key resistance levels.

Short-term momentum improved with price above the SMA20, EMA9, EMA21, and daily VWAP, plus RSI14 at 58.75 and a positive MACD histogram, but TLRY is still below the SMA50 and far below the SMA200, so this remains a rebound inside a larger downtrend rather than a clean bullish swing trend.

You’re looking at 2026-08-05 — about 2 trading days ago.

Subscribers saw this then, and see today’s score, verdict and trade plan now.

Not financial advice. For informational and educational purposes only.